LM-061 / LaNova Medicines Limited  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LM-061 / LaNova Medicines Limited
NCT04882176: A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours

Terminated
1/2
18
RoW
LM-061, Kinase inhibitor
LaNova Medicines Limited
Advanced Tumours
02/23
07/23

Download Options